MAZELSKY JONATHAN JAY (President and CEO) sold 21.8% of their position (23.33K shares) of IDEXX LABORATORIES INC /DE on the open market
Open‑market sale worth $15.34M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+23.33K
Price / share
$141.60
Trade value
$3.30M
% of position
Common Stock
Shares
−1.28K
Price / share
$650.67
Trade value
$833.51K
% of position
Common Stock
Shares
−1.09K
Price / share
$651.49
Trade value
$713.38K
% of position
Common Stock
Shares
−1.67K
Price / share
$652.49
Trade value
$1.09M
% of position
Common Stock
Shares
−1.17K
Price / share
$653.68
Trade value
$765.45K
% of position
Common Stock
Shares
−1.11K
Price / share
$654.63
Trade value
$727.29K
% of position
Common Stock
Shares
−1.49K
Price / share
$655.85
Trade value
$975.90K
% of position
Common Stock
Shares
−1.34K
Price / share
$656.85
Trade value
$882.14K
% of position
Common Stock
Shares
−2.86K
Price / share
$657.84
Trade value
$1.88M
% of position
Common Stock
Shares
−3.66K
Price / share
$658.92
Trade value
$2.41M
% of position
Common Stock
Shares
−2.86K
Price / share
$659.75
Trade value
$1.89M
% of position
Common Stock
Shares
−1.20K
Price / share
$661.10
Trade value
$793.32K
% of position
Common Stock
Shares
−1K
Price / share
$662.16
Trade value
$662.16K
% of position
Common Stock
Shares
−2.59K
Price / share
$663.04
Trade value
$1.72M
% of position
Common Stock
Shares
+197.00
Price / share
$505.53
Trade value
$99.59K
% of position
Net shares
+197.00
Net value
-$11.94M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | M · Option Exercise | +23.33K | $141.60 | $3.30M | 27.9% | 83.61K | 106.93K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.28K | $650.67 | $833.51K | 1.2% | 106.93K | 105.65K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.09K | $651.49 | $713.38K | 1.0% | 105.65K | 104.56K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.67K | $652.49 | $1.09M | 1.6% | 104.56K | 102.89K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.17K | $653.68 | $765.45K | 1.1% | 102.89K | 101.72K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.11K | $654.63 | $727.29K | 1.1% | 101.72K | 100.61K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.49K | $655.85 | $975.90K | 1.5% | 100.61K | 99.12K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.34K | $656.85 | $882.14K | 1.4% | 99.12K | 97.77K |
| Common Stock Direct | 2/26/2026 | S · Sale | −2.86K | $657.84 | $1.88M | 2.9% | 97.77K | 94.91K |
| Common Stock Direct | 2/26/2026 | S · Sale | −3.66K | $658.92 | $2.41M | 3.9% | 94.91K | 91.25K |
| Common Stock Direct | 2/26/2026 | S · Sale | −2.86K | $659.75 | $1.89M | 3.1% | 91.25K | 88.40K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1.20K | $661.10 | $793.32K | 1.4% | 88.40K | 87.20K |
| Common Stock Direct | 2/26/2026 | S · Sale | −1K | $662.16 | $662.16K | 1.1% | 87.20K | 86.20K |
| Common Stock Direct | 2/26/2026 | S · Sale | −2.59K | $663.04 | $1.72M | 3.0% | 86.20K | 83.61K |
| Common Stock Direct | 2/27/2026 | M · Option Exercise | +197.00 | $505.53 | $99.59K | 0.2% | 83.61K | 83.80K |
| Total | +197.00 | -$11.94M | ||||||
Non-Qualified Stock Option (right-to-buy)
Common Stock
23.33K shares
Shares
−23.33K
Strike price
141.60
Held after
0.00
Exercisable
—
Incentive Stock Option (right-to-buy)
Common Stock
197.00 shares
Shares
−197.00
Strike price
505.53
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy) Direct | Common Stock23.33K shares | 2/26/2026 | M · Option Exercise | −23.33K | 141.60 | — | 0.00 |
| Incentive Stock Option (right-to-buy) Direct | Common Stock197.00 shares | 2/27/2026 | M · Option Exercise | −197.00 | 505.53 | — | 0.00 |